Back to search

Article

EFNB1 level affects drug response in DLBCL cell lines

2023-01-03

Abstract excerpt

<h4>ABSTRACT</h4> Targeted therapy was a promising therapy for aggressive B-cell lymphoma. However, drug resistance was still an unavoidable problem. Here, we explored the effect of EFNB1 on drug response. Analysis of IC50 data showed that high level of EFNB1 was associated with resistance to most targeted drugs targeting BCR in human DLBCL cell lines. Drug response assay showed that Efnb1 could enhance SRC phosp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c9fda5ad-b3ae-5871-a7ed-40d8fb85ed8a
DOI
10.1101/2023.01.03.522579
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
EFNB1 level affects drug response in DLBCL cell linesDOI 10.1101/2023.01.03.522579
Comprehensive Analysis of Eph-Ephrin as Novel DLBC Biomarkers for Molecular Subtyping and the Predictability in Prognosis and Drug ResponseSemantic proximity
Clinical and molecular characteristics, transcriptome, and drug efficacy of ERBB2 tyrosine kinase and non-tyrosine kinase mutations in non-small cell lung cancerSemantic proximity
CKS1B as Drug Resistance-Inducing Gene—A Potential Target to Improve Cancer TherapySemantic proximity
Targeted sequencing reveals the relationship between mutations and patients' clinical indicators, blood cell counts and early progression in diffuse large-B cell lymphoma.Semantic proximity
Multiple Omics Analysis Reveals E2F5 Predict Prognostic Biomarker in Diffuse Large B-Cell LymphomaSemantic proximity
Mechanisms of chemoresistance in diffuse large B‑cell lymphoma and novel therapeutic strategies (Review).Semantic proximity
RNA-seq and integrated network analysis reveals the hub genes and key pathway of paclitaxel inhibition on Adriamycin resistant diffuse large B cell lymphoma cellsSemantic proximity
Unveiling immunological and prognostic potential of FBXO2 in BC based on Pan-Cancer and Single cell analysesSemantic proximity
FOXP1-GINS1 axis promotes DLBCL proliferation and directs doxorubicin resistanceSemantic proximity
Role of Differentially Expressed Proteins in Acquired Resistance to Cdk4/6 Inhibitor in Breast CancerSemantic proximity
A Genetic Predictive Model for Precision Treatment of Diffuse Large B-cell Lymphoma with Early ProgressionSemantic proximity
ErbB/HER family in cancer immunology: therapeutic advances and mechanismsSemantic proximity
Select a neighboring publication to make it the new centre.